Vivitrol 380mg Inj, 1 Vial

Manufacturer ALKERMES Active Ingredient Naltrexone Injection(nal TREKS one) Pronunciation nal TREKS one
It is used to help keep you alcohol- free.It is used to help keep you opioid-free. Opioid drugs include heroin and prescription pain drugs like oxycodone and morphine.It may be given to you for other reasons. Talk with the doctor.
🏷️
Drug Class
Opioid antagonist; Alcohol dependence treatment; Opioid dependence treatment
🧬
Pharmacologic Class
Opioid receptor antagonist
🀰
Pregnancy Category
C
βœ…
FDA Approved
Apr 2006
βš–οΈ
DEA Schedule
Not Controlled

Overview

ℹ️

What is this medicine?

Vivitrol is an injectable medicine given once a month to help people who are recovering from alcohol dependence or opioid dependence. It works by blocking the effects of alcohol and opioids in the brain, which can help reduce cravings and prevent relapse. It does not cause a 'high' and is not addictive.
πŸ“‹

How to Use This Medicine

To use this medication correctly, follow your doctor's instructions and read all accompanying information carefully. Take this medication exactly as directed, and be sure to follow all instructions provided. This medication is administered via injection into a muscle.

If you need to store this medication at home, consult with your doctor, nurse, or pharmacist to determine the proper storage procedure.

If you miss a dose, contact your doctor immediately to receive guidance on the appropriate course of action.
πŸ’‘

Lifestyle & Tips

  • You must be completely opioid-free for at least 7-14 days before starting Vivitrol to avoid severe withdrawal symptoms.
  • Carry a medical alert card or wear a medical alert bracelet stating you are taking naltrexone, as it blocks the effects of opioids and could complicate emergency pain management.
  • Do not try to overcome the blockade by taking large amounts of opioids, as this can lead to a fatal overdose.
  • Avoid alcohol and illicit opioids while on treatment.
  • Attend counseling and support groups as part of your treatment plan.
πŸ’Š

Available Forms & Alternatives

Available Strengths:

Dosing & Administration

πŸ‘¨β€βš•οΈ

Adult Dosing

Standard Dose: 380 mg intramuscularly (IM) every 4 weeks (or monthly)
Dose Range: 380 - 380 mg

Condition-Specific Dosing:

Alcohol Dependence: 380 mg IM every 4 weeks (or monthly)
Opioid Dependence: 380 mg IM every 4 weeks (or monthly), following a 7-14 day opioid-free period
πŸ‘Ά

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established
Adolescent: Not established
βš•οΈ

Dose Adjustments

Renal Impairment:

Mild: No specific dose adjustment recommended, use with caution
Moderate: No specific dose adjustment recommended, use with caution
Severe: Use with caution; monitor for adverse reactions due to increased exposure to naltrexone and its active metabolite. Specific dose adjustment not defined.
Dialysis: Not available

Hepatic Impairment:

Mild: No specific dose adjustment recommended, use with caution
Moderate: No specific dose adjustment recommended, use with caution
Severe: Contraindicated in acute hepatitis or liver failure. Use with caution in patients with mild to moderate hepatic impairment; monitor liver function.
Confidence: Medium

Pharmacology

πŸ”¬

Mechanism of Action

Naltrexone is an opioid receptor antagonist. It competitively binds to mu, delta, and kappa opioid receptors in the central nervous system and periphery, with the highest affinity for the mu receptor. This binding blocks the effects of exogenous opioids and reduces alcohol craving, though the exact mechanism for reducing alcohol craving is not fully understood but is thought to involve modulation of the endogenous opioid system.
πŸ“Š

Pharmacokinetics

Absorption:

Bioavailability: Not applicable (IM injection, designed for sustained release)
Tmax: Naltrexone: approximately 2-3 hours (initial peak) and 2-3 days (second peak); 6-beta-naltrexol: approximately 6 hours (initial peak) and 5-7 days (second peak)
FoodEffect: Not applicable (IM injection)

Distribution:

Vd: Naltrexone: approximately 1350 L; 6-beta-naltrexol: approximately 2900 L
ProteinBinding: Naltrexone: approximately 21%; 6-beta-naltrexol: approximately 18%
CnssPenetration: Yes

Elimination:

HalfLife: Naltrexone: approximately 5-10 days (from ER injection); 6-beta-naltrexol: approximately 8-12 days
Clearance: Not available (complex due to sustained release)
ExcretionRoute: Primarily renal (as metabolites)
Unchanged: Less than 1% (naltrexone) and less than 10% (6-beta-naltrexol) excreted unchanged in urine
⏱️

Pharmacodynamics

OnsetOfAction: Within minutes (for opioid receptor blockade, though sustained release provides continuous effect)
PeakEffect: Naltrexone concentrations peak at 2-3 hours and again at 2-3 days post-injection; 6-beta-naltrexol peaks at 6 hours and again at 5-7 days.
DurationOfAction: At least 4 weeks (due to extended-release formulation)

Safety & Warnings

⚠️

BLACK BOX WARNING

HEPATOCELLULAR INJURY: Naltrexone has the potential to cause hepatocellular injury. Patients should be warned of the risk of hepatocellular injury and advised to seek medical attention if they experience symptoms of acute hepatitis. Use of Vivitrol is contraindicated in patients with acute hepatitis or liver failure.

RISK OF OPIOID OVERDOSE: Patients being treated with Vivitrol should be warned of the risk of opioid overdose if they attempt to overcome the opioid blockade. Vivitrol blocks the effects of exogenous opioids. This opioid blockade can be overcome by administering large doses of opioids, which could result in a fatal overdose or other serious life-threatening consequences (e.g., respiratory arrest, circulatory collapse). Patients should be informed that they may be more sensitive to opioids, even at lower doses, after Vivitrol treatment is discontinued.
⚠️

Side Effects

Serious Side Effects: Seek Medical Attention Immediately

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical help right away:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of liver problems, including:
+ Dark urine
+ Tiredness
+ Decreased appetite
+ Upset stomach or stomach pain
+ Light-colored stools
+ Vomiting
+ Yellow skin or eyes
Signs of high blood pressure, such as:
+ Severe headache or dizziness
+ Passing out
+ Changes in eyesight
New or worsening behavioral or mood changes, including:
+ Depression
+ Thoughts of suicide
+ Confusion
Breathing difficulties, such as:
+ Slow breathing
+ Shallow breathing
Sexual problems in males
Signs of lung or breathing problems, including:
+ Shortness of breath
+ Trouble breathing
+ Cough
+ Fever
Severe skin irritation at the injection site, characterized by:
+ Hardness
+ Blisters
+ Dark scab
+ Lumps
+ Open wound
+ Pain
+ Swelling

Other Possible Side Effects

Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to contact your doctor or seek medical help if you notice any of the following:

Feeling nervous or excitable
Anxiety
Headache
Muscle cramps
Constipation
Diarrhea
Stomach pain
Upset stomach
Vomiting
Decreased appetite
Excessive thirst
Sleep disturbances
Dizziness
Drowsiness
Fatigue
Weakness
Back pain
Muscle pain
Joint pain
Common cold symptoms
Tooth pain
Irritation at the injection site
Nose or throat irritation
Dry mouth

This list is not exhaustive, and you may experience other side effects not mentioned here. If you have concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Signs of liver problems: severe stomach pain, dark urine, yellowing of your skin or the whites of your eyes (jaundice), unusual tiredness, nausea, vomiting, loss of appetite.
  • Depression or suicidal thoughts/behaviors: new or worsening depression, thoughts of harming yourself or others.
  • Injection site reactions: severe pain, swelling, blistering, open wound, or a dark scab at the injection site.
  • Pneumonia: cough, shortness of breath, chest pain.
  • Allergic reactions: rash, swelling of your face, eyes, lips, or tongue, trouble breathing.
πŸ“‹

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction and its symptoms.
If you are currently taking or have recently taken an opioid medication, such as morphine or oxycodone, or if you have an opioid use disorder or are experiencing withdrawal symptoms.
* If you have taken a pain medication within the past 7 to 14 days.

This list is not exhaustive, and it is crucial to discuss all your medications, including prescription and over-the-counter drugs, natural products, and vitamins, with your doctor and pharmacist. They will help determine if it is safe to take this medication with your existing medications and health conditions.

Remember, do not start, stop, or change the dosage of any medication without first consulting your doctor to ensure your safety.
⚠️

Precautions & Cautions

Important Warnings and Precautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. This will help ensure your safety and prevent potential interactions with other treatments.

Caution with Daily Activities
Until you know how this medication affects you, avoid driving and engaging in activities that require you to be alert. This will help prevent accidents and ensure your safety.

Monitoring and Lab Tests
Your doctor will schedule regular blood work and other lab tests to monitor your condition. It is crucial to keep these appointments and follow your doctor's instructions. Additionally, inform all your healthcare providers and lab workers that you are taking this medication, as it may affect certain lab test results.

Interactions with Other Substances
Do not consume alcohol while taking this medication. It is also essential to avoid taking opioid drugs, as they will not be effective and may cause severe harm, including coma or death, if taken in excess. If you have taken opioid drugs in the past, be aware that low doses or amounts you have used before may lead to overdose and death after receiving this medication.

Opioid Overdose Risk
After receiving a dose of this medication, its blocking effect on opioids will gradually decrease over time. If you miss a dose, stop treatment, or have completed treatment and are opioid-free, you may be at risk of overdose and death if you take opioid drugs. A medication called naloxone can be used to help treat an opioid overdose. Your doctor may prescribe naloxone for you to have on hand in case of an emergency. If you have questions about naloxone or suspect an opioid overdose, seek medical attention immediately, even if naloxone has been administered.

Opioid Withdrawal Symptoms
If you have opioid use disorder and are given this medication, you may experience symptoms of opioid withdrawal, such as sweating, shaking, fever, chills, diarrhea, stomach upset, vomiting, stomach cramps, goosebumps, body aches, anxiety, irritability, yawning, or rapid heartbeat.

Skin and Lung Infection Risks
In rare cases, severe skin problems can occur at the injection site, potentially requiring surgical intervention. Additionally, a type of lung infection caused by an allergic reaction has been reported with this medication, which may require hospitalization. Inform your doctor immediately if you experience any unusual symptoms.

Pregnancy and Breastfeeding
If you are pregnant, plan to become pregnant, or are breastfeeding, inform your doctor. It is essential to discuss the benefits and risks of this medication to you and your baby.
πŸ†˜

Overdose Information

Overdose Symptoms:

  • If you attempt to overcome the blockade by taking large doses of opioids, symptoms of overdose may include: severe respiratory depression (slow, shallow breathing), extreme drowsiness, pinpoint pupils, cold and clammy skin, loss of consciousness, circulatory collapse, death.

What to Do:

Seek immediate emergency medical attention. Inform medical personnel that you are on naltrexone. Higher than usual doses of opioid antagonists (e.g., naloxone) may be required to reverse the effects of an opioid overdose in a patient on naltrexone. Call 911 or 1-800-222-1222 (Poison Control).

Drug Interactions

🚫

Contraindicated Interactions

  • Opioid analgesics (e.g., morphine, oxycodone, hydrocodone, fentanyl, tramadol)
  • Patients receiving opioid analgesics
  • Patients in acute opioid withdrawal
  • Patients who have failed the naloxone challenge test or have a positive urine screen for opioids
πŸ”΄

Major Interactions

  • Other hepatotoxic drugs (e.g., acetaminophen in high doses, isoniazid, amiodarone, methotrexate) - increased risk of liver injury
  • Thioridazine (potential for increased somnolence and lethargy)
🟑

Moderate Interactions

  • Opioid-containing cough, cold, or antidiarrheal medications (e.g., codeine, loperamide) - naltrexone will block their effects
  • Disulfiram (potential for additive hepatotoxicity, though not well-established)

Monitoring

πŸ”¬

Baseline Monitoring

Liver Function Tests (LFTs) including ALT, AST, bilirubin

Rationale: To assess baseline hepatic function due to risk of hepatocellular injury

Timing: Prior to initiation of Vivitrol

Opioid-free status verification (e.g., urine drug screen, naloxone challenge test)

Rationale: To ensure patient is opioid-free for 7-14 days to avoid precipitating acute opioid withdrawal

Timing: Prior to first dose of Vivitrol

Pregnancy test (for females of childbearing potential)

Rationale: To assess pregnancy status due to Category C classification

Timing: Prior to initiation

πŸ“Š

Routine Monitoring

Liver Function Tests (LFTs)

Frequency: Periodically, or as clinically indicated (e.g., if symptoms of liver injury develop)

Target: Within normal limits or stable

Action Threshold: Discontinue Vivitrol if LFTs exceed 3-5 times upper limit of normal or if patient develops signs/symptoms of acute hepatitis.

Injection site reactions

Frequency: At each visit, and patient self-monitoring

Target: Minimal redness/swelling

Action Threshold: Assess for severe pain, induration, cellulitis, abscess, or necrosis; may require medical intervention.

Mental status (for depression, suicidal ideation)

Frequency: At each visit

Target: Stable mood, absence of suicidal ideation

Action Threshold: Assess for worsening depression or emergence of suicidal thoughts/behaviors; consider psychiatric evaluation.

Adherence to treatment plan and abstinence from opioids/alcohol

Frequency: At each visit

Target: Consistent adherence, sustained abstinence

Action Threshold: Address non-adherence or relapse; provide counseling and support.

πŸ‘οΈ

Symptom Monitoring

  • Signs/symptoms of liver injury (e.g., abdominal pain, dark urine, jaundice, fatigue, nausea, vomiting)
  • Signs/symptoms of depression or suicidal ideation
  • Severe injection site reactions (e.g., pain, swelling, induration, blistering, open wound, necrosis)
  • Signs of opioid withdrawal (if patient attempts to use opioids while on naltrexone)
  • Pneumonia (rare, but reported in clinical trials)

Special Patient Groups

🀰

Pregnancy

Category C. Vivitrol should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. There are no adequate and well-controlled studies in pregnant women. Animal studies have shown adverse effects.

Trimester-Specific Risks:

First Trimester: Potential for fetal harm based on animal data; human data limited.
Second Trimester: Potential for fetal harm based on animal data; human data limited.
Third Trimester: Potential for fetal harm based on animal data; human data limited.
🀱

Lactation

L3 (Moderately Safe). Naltrexone and its active metabolite are excreted into human milk. The effect on the breastfed infant is unknown. Weigh the developmental and health benefits of breastfeeding along with the mother’s clinical need for Vivitrol and any potential adverse effects on the breastfed infant from Vivitrol or from the underlying maternal condition.

Infant Risk: Potential for sedation, poor feeding, or withdrawal symptoms if infant is exposed to opioids. Monitor infant for adverse effects.
πŸ‘Ά

Pediatric Use

Safety and effectiveness in pediatric patients (under 18 years of age) have not been established for alcohol or opioid dependence.

πŸ‘΄

Geriatric Use

No specific dose adjustment is recommended based on age. However, elderly patients may have decreased renal or hepatic function, which should be considered. Monitor for adverse effects and comorbidities.

Clinical Information

πŸ’Ž

Clinical Pearls

  • Ensure a 7-14 day opioid-free period before initiating Vivitrol to prevent precipitated opioid withdrawal, which can be severe and require hospitalization.
  • Administer Vivitrol as a deep intramuscular gluteal injection, alternating buttocks for subsequent injections. Do not administer intravenously or subcutaneously.
  • Educate patients thoroughly about the risk of opioid overdose if they attempt to overcome the blockade, emphasizing that even after discontinuing Vivitrol, they may be more sensitive to opioids.
  • Vivitrol does not eliminate cravings for all individuals; it is most effective when used as part of a comprehensive treatment program including counseling and psychosocial support.
  • Monitor injection sites closely for severe reactions, which can include necrosis and require surgical intervention.
  • Patients should be advised to carry identification indicating they are on naltrexone, especially in case of an emergency where opioid analgesia might be needed.
πŸ”„

Alternative Therapies

  • Oral naltrexone (Revia, Depade) - for alcohol and opioid dependence
  • Acamprosate (Campral) - for alcohol dependence
  • Disulfiram (Antabuse) - for alcohol dependence
  • Buprenorphine/naloxone (Suboxone, Zubsolv, Bunavail) - for opioid dependence
  • Methadone - for opioid dependence
πŸ’°

Cost & Coverage

Average Cost: $1,500 - $2,000+ per 380mg vial
Insurance Coverage: Often Tier 3 or Specialty Drug; requires prior authorization and may have specific coverage criteria.
πŸ“š

General Drug Facts

If your symptoms or health problems do not improve or worsen over time, it is essential to contact your doctor for further evaluation and guidance. To ensure safe and effective treatment, never share your medication with others or take someone else's medication.

Store all medications in a secure location, out of the reach of children and pets, to prevent accidental ingestion. Properly dispose of unused or expired medications by checking with your pharmacist for guidance on the best disposal method. Unless instructed to do so, avoid flushing medications down the toilet or pouring them down the drain, as this can harm the environment. Many communities offer drug take-back programs, which provide a safe and responsible way to dispose of unwanted medications.

This medication is accompanied by a Medication Guide, which provides important information about its safe and effective use. Read this guide carefully and review it again each time your prescription is refilled. If you have any questions or concerns about your medication, consult with your doctor, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately contact your local poison control center or seek emergency medical attention. Be prepared to provide information about the medication taken, the amount, and the time it was taken, as this will help healthcare professionals provide the best possible care.